UK Markets close in 1 hr 41 mins

Novo Nordisk A/S (NOVO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
740.30-8.80 (-1.17%)
As of 03:48PM CEST. Market open.
Full screen
Previous close749.10
Bid740.20 x 0
Ask740.20 x 0
Day's range720.40 - 754.50
52-week range475.45 - 834.50
Avg. volume2,056,442
Market cap1.688T
Beta (5Y monthly)0.26
PE ratio (TTM)37.06
Earnings dateN/A
Forward dividend & yield9.35 (1.35%)
Ex-dividend date16 Aug 2021
1y target estN/A
  • Stockopedia

    Assessing the impact of economic shocks on the Novo Nordisk A/S share price

    A question on the minds of many investors right now is how economic uncertainty will continue to affect large cap companies, such as Novo Nordisk A/S (CPH:NOVO...

  • Motley Fool

    3 Unstoppable Stocks to Buy in May

    Prosper Junior Bakiny (Novo Nordisk): For the past several decades, Novo Nordisk has been a leader in the market for diabetes drugs. As of February 2022, the company held a 30.5% share of the diabetes care market, an increase from the 29.3% slice of the pie it had in February 2021. Novo Nordisk's dominance in this therapeutic area is one reason it has outperformed the broader market in each of the past one, five, 10, and 20 years.

  • Zacks

    Prothena (PRTA) Q1 Earnings Beat, Pipeline Progress in Focus

    Prothena beats on earnings and revenues in the first quarter of 2022. The company's progress with its AD pipeline is encouraging.